In the late 1960s, researchers at the Weizmann Institute of Science, including Professors Michael Sela and Ruth Arnon and Dr.

A U.S. court of appeals has reportedly ruled that a whistleblower case against Novartis (NVS) over alleged kickbacks ...

A U.S. appeals court on Friday revived a whistleblower lawsuit accusing Swiss drugmaker Novartis of paying illegal kickbacks ...

A 2016 phase 2 trial found that estriol plus glatiramer acetate (the drug in Copaxone and Glatopa) reduced relapse rates in women with MS and was well tolerated for the two years of the study. This ...

Recent health news includes the FDA's approval of an injectable version of Opdivo, a revived lawsuit against Novartis for ...

INR:1401. btc race club BMS's new multiple sclerosis drug is expected to be approved by the EU Note: Hospitals need to set up a new medical service price management ...

Dark story behind Alice in Wonderland R&D Daily丨Roche's multiple sclerosis drug Ocrevus is approved by the FDA again Common gluc ...

18 months after it opened an investigation into Teva to see if it illegally blocked generic versions of its big-selling multiple sclerosis drug Copaxone, the European Commission has said it thinks ...

sachin tendulkar wife age difference Multiple sclerosis drug development is hot, 14 drugs have been launched overseas, how are domestic research and development/imitation The first multidisciplinary ...

Teva’s Copaxone patent expired in Europe in 2015 and the Commission said it will investigate whether the company broke antitrust rules by defending the drug’s market position after the expiry.

The researchers compared the frequency of spontaneous abortions, infections during pregnancy, premature births and birth ...

Potential New Drug Treatment for Multiple Sclerosis Dec. 8, 2023 — Pre-clinical studies using a small molecule drug have shown promise as a potential new treatment for multiple sclerosis ...